PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
25-Apr-2025 OncoZenge provides update on regulatory status of incoming investment OncoZenge AB
25-Apr-2025 Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ) ACCESS Newswire
25-Apr-2025 Global Aesthetic Medical Device Market Set to Reach USD 18.82 Billion by 2034 Amid Rising Demand for Minimally Invasive Cosmetic Procedures | FMI MARKITWIRED
25-Apr-2025 Global Intradermal Injection Market to reach USD 10,814.47 Million by 2032; growing at a 10.8% CAGR: FMI Report MARKITWIRED
25-Apr-2025 Global Intravenous Iron Drugs Market Set to Surpass USD 6.3 Billion by 2032 amid Rising Prevalence of Iron Deficiency Anaemia | FMI MARKITWIRED
25-Apr-2025 Global Market Analysis Shows Strong Demand for Intrathecal Pumps in Pain Management and Spasticity Treatment | FMI MARKITWIRED
25-Apr-2025 Reproductive Health Supplements from Ovaterra at the Cutting Edge of Fertility Support ACCESS Newswire
25-Apr-2025 ClearPoint Neuro to Announce First Quarter 2025 Results May 13, 2025 ACCESS Newswire
25-Apr-2025 Bausch Health Announces Launch of Solta Medical's Fraxel FTX(TM) ACCESS Newswire
25-Apr-2025 Xlife Sciences AG publishes 2024 Annual Report: Strategic Expansion, Technological Milestones, and International Capital Market Presence Xlife Sciences AG
25-Apr-2025 iZafe Group Q1 Interim Report, January-March 2025 ACCESS Newswire
24-Apr-2025 Onco-Innovations' Inka Health Signs New Analytical Work with AstraZeneca Canada to Advance Real-World Evidence in Regulatory Science ACCESS Newswire
24-Apr-2025 Ensysce Biosciences, Inc. Announces Closing of Exercise of Warrants for $2.2 Million Gross Proceeds ACCESS Newswire
24-Apr-2025 2024 FULL YEAR RESULTS Affluent Medical reached major new milestones in executing its clinical roadmap Affluent Medical SA
24-Apr-2025 Heidelberg Pharma AG: Interim Statement on the First Three Months of Financial Year 2025 Heidelberg Pharma AG
24-Apr-2025 OXB Named Among UK’s Best Employers by Financial Times in 2025 OXB
24-Apr-2025 Bioxodes announces positive Phase 2a interim data for BIOX-101 in intracerebral hemorrhagic stroke patients Bioxodes
24-Apr-2025 Mosaic Therapeutics in-licences two clinical-stage assets from Astex Pharmaceuticals Syncona Limited
24-Apr-2025 HUTCHMED Highlights Data to be Presented at AACR Annual Meeting 2025 HUTCHMED
24-Apr-2025 Hikma reiterates full year guidance following good start to the year Hikma